Cardiac Science to Supply Powerheart G3 AEDs to Chicago Metra

        Cardiac Science to Supply Powerheart G3 AEDs to Chicago Metra

Metra becomes second transit agency in country to deploy AEDs on all its
commuter trains

PR Newswire

WAUKESHA, Wis., Jan. 7, 2013

WAUKESHA, Wis., Jan. 7, 2013 /PRNewswire/ -- Cardiac Science Corporation, an
Opto Circuits group company and a global leader in automated external
defibrillators (AEDs) and diagnostic cardiac monitoring devices, will supply
Powerheart® G3 AEDs to all Chicago-area Metra commuter trains and other Metra
facilities by the end of January.

(Logo: http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO)

Under terms of the agreement, Cardiac Science will deploy 440 AEDs in Metra
passenger cars, work facilities, and police vehicles; Cardiac Science also
donated 30 AEDs to Metra. The deployment was made possible with a grant from
the Regional Transportation Authority, sponsorship of Northwestern Medicine,
and support of Illinois Governor Patrick Quinn.

Metra recorded nearly 82.7 million passenger trips in 2011, and is now the
second transit system in the country to deploy AEDs on all of its trains.

"We are honored that Metra chose Cardiac Science to be the AED provider in its
public access defibrillator (PAD) program," said Neal Long, Cardiac Science
president and chief executive officer. "Allowing passengers, workers, and
emergency personnel with easy access to defibrillators will combat sudden
cardiac arrest and save lives."

At a press conference at a downtown Chicago Metra station on Dec. 27, Governor
Quinn further underscored the importance of AEDs. "Having AEDs readily
available on Metra cars will save lives," said Governor Quinn. "By being
prepared, we can be ready to respond swiftly and safely in the unfortunate
event of a medical emergency. By working together, we can get these critical
devices in public spaces everywhere."

Governor Quinn signed the Good Samaritan Act into law in 2011 to provide Good
Samaritan coverage for anyone who has successfully completed American Heart
Association or American Red Cross AED training. It protects trained AED users
from liability as long as they act in good faith.

About Cardiac Science

Cardiac Science, group company of Opto Circuits (India) Ltd., develops,
manufactures, and markets a family of advanced diagnostic and therapeutic
cardiology devices and systems, including automated external defibrillators
(AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and
systems, PC-based diagnostic workstations, Holter monitoring systems, hospital
defibrillators, vital signs monitors, cardiac rehabilitation telemetry
systems, and cardiology data management systems (informatics) that connect
with hospital information (HIS), electronic medical record (EMR), and other
information systems. The company sells a variety of related products and
consumables and provides a portfolio of training, maintenance, and support
services. Cardiac Science, the successor to the cardiac businesses that
established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton®
brands, is headquartered in Bothell, Washington. With customers in almost 100
countries worldwide, the company has operations in North America, Europe, and
Asia. For information, call 425.402.2000 or visit
http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac
monitoring, find us on Facebook at http://facebook.com/cardiacscience, the
Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at
http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT

For media questions, contact Ric Kositzke at +1.262.798.7624.

For investor questions, contact Opto Circuits at ir@optoindia.com or
+91.80.2852.8088.

SOURCE Cardiac Science Corporation

Website: http://www.cardiacscience.com